Wednesday, March 30, 2016

BRIEF-Dynavax says FDA has scheduled Sept 15 as action date for heplisav-b

March 30 (Reuters) - Dynavax Announces Fda Acceptance For

Review Of Biologics License Application And Pdufa Action Date

For Heplisav

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)